Hello. Sign In
Standards Store

ASTM F2529

2013 Edition, February 1, 2013

Complete Document

Standard Guide for in vivo Evaluation of Osteoinductive Potential for Materials Containing Demineralized Bone (DBM)



Detail Summary

Active, Most Current

EN
Format
Details
Price (USD)
PDF
Single User
$52.00
Print
In Stock
$52.00
PDF + Print
In Stock
$88.40 You save 15%
Add to Cart

People Also Bought These:

ASTM A313/A313M
ASQ Z1.4
ASME Y14.5
ASME Y14.100

Product Details:

  • Revision: 2013 Edition, February 1, 2013
  • Published Date: February 1, 2013
  • Status: Active, Most Current
  • Document Language: English
  • Published By: ASTM International (ASTM)
  • Page Count: 16
  • ANSI Approved: No
  • DoD Adopted: No

Description / Abstract:

This guide covers general guidelines to evaluate the effectiveness of DBM-containing products intended to cause and/or promote bone formation when implanted or injected in vivo. This guide is applicable to products that may be composed of one or more of the following components: natural biomaterials (such as demineralized bone), and synthetic biomaterials (such as calcium sulfate, glycerol, and reverse phase polymeric compounds) that act as additives, fillers, and/or excipients (radioprotective agents, preservatives, and/or handling agents) to make the demineralized bone easier to manipulate. It should not be assumed that products evaluated favorably using this guidance will form bone when used in a clinical setting. The primary purpose of this guide is to facilitate the equitable comparison of unique bone-forming products in in vivo heterotopic models of osteoinductivity. The purpose of this guide is not to exclude other established methods.

The values stated in SI units are to be regarded as standard. No other units of measurement are included in this standard.

This standard does not purport to address all of the safety concerns, if any, associated with the use of DBMcontaining bone-forming/promoting products. It is the responsibility of the user of this standard to establish appropriate safety and health practices involved in the development of said products in accordance with applicable regulatory guidance documents and in implementing this guide to evaluate the bone-forming/promoting capabilities of the product.